What are the needs for clinical application of next-generation sequencing for microbiological diagnosis?

The FDA re­ject­ed lin­voseltam­ab, Re­gen­eron’s ex­per­i­men­tal an­ti­body for mul­ti­ple myelo­ma, the com­pa­ny an­nounced Wednes­day morn­ing. In an earn­ings call ear­li­er this … Sign up to

A 2024 meta-analysis on psilocybin’s effects on depression published in The BMJ was corrected earlier this week following methodological errors, but conclusions indicating a benefit